TGFBR3L and neoplasm: Only four tumour samples presented between 10 and 30% (n = 3) or ≥ 30% cells (n = 1) positive for TGFBR3L, and for the purpose of further statistical analyses, we decided to dichotomize into negative and positive tumours.